Target type: cellularcomponent
A protein complex that comprises four pore-forming (Kir6.x) and four regulatory sulphonylurea receptor (SURx) subunits and forms a transmembrane channel through which ions may pass. The opening and closing of the channel is regulated by ATP: binding of ATP to the Kir6.x subunit inhibits channel activity, whereas binding of Mg2+-complexed ATP or ADP to the SURx subunit stimulates channel activity. [GOC:bhm, PMID:16308567, PMID:16956886]
Inward rectifying potassium channels (Kir channels) are a diverse family of ion channels that play crucial roles in regulating membrane potential, cell excitability, and various physiological processes. They are characterized by their ability to conduct potassium ions (K+) more readily inward than outward, a property that arises from their unique structure and gating mechanisms.
**Cellular Component:**
Kir channels are integral membrane proteins embedded within the plasma membrane of cells. They are typically tetrameric, meaning they are composed of four identical or similar subunits that assemble to form a functional channel. Each subunit consists of two transmembrane domains (TM1 and TM2) and a pore loop that lines the ion-conducting pathway.
**Specific Features:**
* **Pore Loop:** The pore loop is a critical structural element that determines the channel's selectivity for potassium ions. It contains a series of amino acid residues that interact with the hydrated K+ ions, facilitating their passage through the channel.
* **Gating Mechanism:** Kir channels exhibit a characteristic inward rectification property, which arises from the voltage-dependent gating of the channel. When the membrane potential is negative (i.e., inside of the cell is more negative than outside), the channel is open, allowing K+ ions to flow inward. As the membrane potential becomes more positive, the channel progressively closes, limiting outward K+ current.
* **Regulation:** The activity of Kir channels can be regulated by various factors, including:
* **Membrane Potential:** As described above, membrane potential plays a significant role in gating Kir channels.
* **Intracellular pH:** Some Kir channels are sensitive to changes in intracellular pH, with acidic pH often inhibiting channel activity.
* **Binding of Ligands:** Certain Kir channels are regulated by the binding of specific intracellular ligands, such as ATP or PIP2.
* **Phosphorylation:** Phosphorylation of Kir channel subunits by kinases can modulate their activity.
**Functional Significance:**
Kir channels are essential for a wide range of physiological processes, including:
* **Maintaining Resting Membrane Potential:** Kir channels contribute significantly to the maintenance of the resting membrane potential of various cells, including neurons, muscle cells, and cardiac cells.
* **Regulating Cell Excitability:** Kir channels can influence the excitability of cells by controlling the flow of potassium ions across the membrane, which can affect the firing rate of neurons or the contraction of muscle cells.
* **Controlling Heart Rhythm:** Kir channels play critical roles in the electrical activity of the heart, contributing to the regulation of heart rate and rhythm.
* **Maintaining Intracellular pH:** Some Kir channels are involved in regulating intracellular pH, which is essential for various cellular processes.
* **Modulating Neuronal Signaling:** Kir channels in neurons influence synaptic transmission and neuronal excitability.
**Diversity of Kir Channels:**
The Kir channel family consists of several subfamilies, each with distinct structural and functional properties. These subfamilies include:
* **Kir1:** These channels are often expressed in neurons and are involved in neuronal signaling and regulation of membrane potential.
* **Kir2:** These channels are found in a wide variety of tissues and are known for their role in maintaining resting membrane potential and regulating cell excitability.
* **Kir3:** These channels are involved in regulating cardiac rhythm and are often referred to as G protein-coupled inwardly rectifying potassium channels (GIRKs).
* **Kir4:** These channels are primarily expressed in astrocytes, where they contribute to potassium buffering in the brain.
* **Kir5:** These channels are found in the kidneys and are involved in regulating potassium excretion.
**Clinical Relevance:**
Dysfunction of Kir channels has been implicated in a variety of diseases, including:
* **Cardiac Arrhythmias:** Mutations in Kir channels can lead to irregular heart rhythms and heart disease.
* **Neuropathies:** Abnormal Kir channel function can contribute to neurological disorders, including epilepsy and autism spectrum disorders.
* **Diabetes:** Kir channels are involved in glucose uptake and metabolism, and mutations in these channels can affect insulin sensitivity and diabetes.
* **Cancer:** Some Kir channels have been implicated in cancer development and progression.
**Conclusion:**
Inward rectifying potassium channels are a diverse and essential family of ion channels that play crucial roles in regulating membrane potential, cell excitability, and a wide range of physiological processes. Their unique structure, gating mechanisms, and diverse subfamilies make them key players in maintaining cellular homeostasis and ensuring proper function of various organs and tissues. Understanding the intricacies of Kir channel function is critical for gaining insights into various physiological processes and developing therapeutic strategies for related diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
ATP-sensitive inward rectifier potassium channel 8 | An ATP-sensitive inward rectifier potassium channel 8 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q15842] | Homo sapiens (human) |
ATP-sensitive inward rectifier potassium channel 11 | An ATP-sensitive inward rectifier potassium channel 11 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q14654] | Homo sapiens (human) |
ATP-binding cassette sub-family C member 8 | An ATP-binding cassette sub-family C member 8 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q09428] | Homo sapiens (human) |
ATP-binding cassette sub-family C member 9 | An ATP-binding cassette sub-family C member 9 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O60706] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
diazoxide | diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies. Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group. | benzothiadiazine; organochlorine compound; sulfone | antihypertensive agent; beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; diuretic; K-ATP channel agonist; sodium channel blocker; sympathomimetic agent; vasodilator agent |
glyburide | glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group. Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide | monochlorobenzenes; N-sulfonylurea | anti-arrhythmia drug; EC 2.7.1.33 (pantothenate kinase) inhibitor; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor; hypoglycemic agent |
pinacidil | Pinacidil: A guanidine that opens POTASSIUM CHANNELS producing direct peripheral vasodilatation of the ARTERIOLES. It reduces BLOOD PRESSURE and peripheral resistance and produces fluid retention. (Martindale The Extra Pharmacopoeia, 31st ed) | pyridines | |
propafenone | propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias. Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. | aromatic ketone; secondary alcohol; secondary amino compound | anti-arrhythmia drug |
troglitazone | Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity. | chromanes; thiazolidinone | anticoagulant; anticonvulsant; antineoplastic agent; antioxidant; EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; hypoglycemic agent; platelet aggregation inhibitor; vasodilator agent |
n-cyano-n'-(1,1-dimethylpropyl)-n''-(3-pyridinyl)guanidine | N-cyano-N'-(1,1-dimethylpropyl)-N''-(3-pyridinyl)guanidine: potassium channel opener | pyridines | |
repaglinide | piperidines | ||
cromakalim | Cromakalim: A potassium-channel opening vasodilator that has been investigated in the management of hypertension. It has also been tried in patients with asthma. (Martindale, The Extra Pharmacopoeia, 30th ed, p352) | ||
rosiglitazone | aminopyridine; thiazolidinediones | EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; insulin-sensitizing drug | |
mk 767 | 5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide: an antihyperlipidemic agent that also functions as an insulin sensitizer, PPARalpha agonist, and PPARgamma agonist; structure in first source | ||
zeneca zd 6169 | Zeneca ZD 6169: an ATP-sensitive potassium channel opener; structure given in first source | ||
cromakalim | 1-benzopyran | ||
clamikalant | clamikalant: inhibits ATP-sensitive potassium channel; structure in first source | ||
zm226600 | ZM226600: an ATP-sensitive potassium channel opener; structure in first source | anilide | |
way 133537 | |||
ly 465608 | LY 465608: a nonthiazolidinedione agonist of both PPAR-alpha and PPAR-gamma of Ligand Pharm. and Eli Lilly | ||
bm 131246 | |||
nn 414 | NN 414: a hypoglycemic agent with insulin release modulating and potassium channel activating activities; structure in first source | ||
7-chloro-3-isopropylamino-4h-1,2,4-benzothiadiazine 1,1-dioxide | 7-chloro-3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxide: activates ATP-sensitive potassium channels; structure in first source |